Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 11.

Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report
Title: Certain Symptoms Can Delay Lupus Diagnosis, Researchers ReportCategory: Health NewsCreated: 8/19/2014 7:36:00 PMLast Editorial Review: 8/20/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 20, 2014 Category: Rheumatology Source Type: news

Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report
Headache, seizures often lead doctors down the wrong path (Source: WebMD Health)
Source: WebMD Health - August 20, 2014 Category: Consumer Health News Source Type: news

Certain Symptoms Can Delay Lupus Diagnosis, Researchers Report
Headache, seizures often lead doctors down the wrong path Source: HealthDay Related MedlinePlus Page: Lupus (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 19, 2014 Category: Consumer Health News Source Type: news

Genetic key to lupus shows potential of personalized medicine
DNA sequencing of a lupus patient has identified a specific genetic mutation that is causing the disease, opening the way for personalized treatments. Researchers identified a variant in the TREX1 gene. This mutation caused the patient's cells to produce a molecule called interferon-alpha. Clinical trials are already underway for drugs to target interferon-alpha in adults. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 19, 2014 Category: Science Source Type: news

Rheumatologic diseases like lupus can initially look like neurological disorders
(Loyola University Health System) Lupus and other rheumatologic diseases can initially present as neurological disorders such as headaches and seizures, and thus delay diagnosis for many months. And treatments can cause adverse neurological effects. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 18, 2014 Category: Global & Universal Source Type: news

What Causes Proteinuria?
Discussion Proteinuria occurs relatively often in pediatric practice with 5-15% of school children having transient proteinuria, the most common cause. However, proteinuria can be a sign of kidney disease. Therefore, it is important to evaluate the proteinuria in light of the clinical situation. A good history and physical examination along with a full urinalysis and/or BUN and creatinine, or urine protein/creatinine ratio may be all that is necessary. Another patient with edema, hypertension or hematuria needs a fuller evaluation and treatment. Proteinuria is usually categorized into three groups to assist with evaluation...
Source: PediatricEducation.org - August 18, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Lupus Patients Face High Rehospitalization Rates
Title: Lupus Patients Face High Rehospitalization RatesCategory: Health NewsCreated: 8/11/2014 12:36:00 PMLast Editorial Review: 8/12/2014 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - August 12, 2014 Category: Rheumatology Source Type: news

Lupus Patients Face High Rehospitalization Rates
Drugs that suppress the immune system make it harder to fight infection, study says (Source: WebMD Health)
Source: WebMD Health - August 11, 2014 Category: Consumer Health News Source Type: news

'Worm pill' could ease autoimmune disease symptoms
Experts believe a molecule in parasitic worms could help explain why worm infections can effectively treat a range of autoimmune diseases, including multiple sclerosis, psoriasis, rheumatoid arthritis and lupus. The study successfully identified peptides from parasitic worms that suppress the body's immune response. Researchers believe this could pave the way for a new drug containing the peptide to provide relief from the symptoms of autoimmune diseases. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 11, 2014 Category: Science Source Type: news

Readmission Rates High in Lupus
(MedPage Today) -- One in six patients with lupus discharged from the hospital was readmitted within a month, with underserved minority populations being most vulnerable, researchers found. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - August 11, 2014 Category: Primary Care Source Type: news

Lupus Patients Face High Rehospitalization Rates
Drugs that suppress the immune system make it harder to fight infection, study says Source: HealthDay Related MedlinePlus Pages: Health Facilities, Lupus, Medicines (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - August 11, 2014 Category: Consumer Health News Source Type: news

One in 6 lupus patients readmitted to hospital within 30 days of discharge
(Wiley) A new study reveals that one in six patients with systemic lupus erythematosus is readmitted to the hospital within 30 days of being discharged. Results published in Arthritis & Rheumatology, a journal of the American College of Rheumatology, show that black and Hispanic systemic lupus erythematosus patients were more likely to be readmitted than white patients. Readmissions among patients insured by Medicare or Medicaid were also more likely compared to patients covered by private insurance. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 11, 2014 Category: Global & Universal Source Type: news

RheumShorts: IL-6 and RA, Life and Death, Surgery in Lupus (CME/CE)
(MedPage Today) -- The September issue of the Annals of the Rheumatic Diseases featured studies on an investigational interleukin-6 inhibitor for rheumatoid arthritis, mortality effects of early remission in inflammatory arthritis, and adverse surgical outcomes for patients with lupus. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - August 6, 2014 Category: Geriatrics Source Type: news

Gabriela Lavezzari on Improving the Lives of Patients with Arthritis
Many people are unaware of the impact of arthritis and related musculoskeletal diseases in the United States. They affect approximately 52.5 million Americans of all ages, races and genders. The biopharmaceutical industry is making great strides towards new treatments with 92 medicines in the pipeline which have the potential to help patients live more active and productive lives. Work on these treatments is more imperative than ever as 67 million people could be diagnosed with some form of musculoskeletal disease by 2030, according to the U.S. Centers for Disease Control and Prevention. Earlier this year, PhRMA joined 10...
Source: PHRMA - August 4, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Overview of Neonatal LupusOverview of Neonatal Lupus
What is the presentation of neonatal lupus and how is it treated? Journal of Pediatric Health Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 4, 2014 Category: Consumer Health News Tags: Pediatrics Journal Article Source Type: news

Stephen I. Katz on Improving the Lives of Patients with Arthritis
To improve the lives of people with arthritis, the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) is working toward a better understanding of the basic biology of diseases affecting the joints, better diagnosis and treatment of arthritis, and better tools to facilitate clinical trials. NIAMS was a key contributor to the development of tofacitinib, the first oral disease modifying antirheumatic drug (DMARD) for rheumatoid arthritis (RA) in a decade, which recently received  approval from the U.S. Food and Drug Administration. In the early 1990’s, NIAMS intramural researchers discovered Janu...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Amanda Niskar on Improving the Lives of Patients with Arthritis
For almost 70 years, the Arthritis Foundation has initiated and supported scientific discoveries that improve health outcomes for people with arthritis. Research holds the key to finding better diagnostics and treatments—and one day a cure—for more than 50 million Americans who face the daily challenges of arthritis. At the Foundation, we are focused on providing scientific leadership and direction to improve everyday life for people with arthritis and to find a cure.   Information from the Medicines in Development report issued by the Pharmaceutical Research Manufacturers of America (PhRMA), about medicines that are ...
Source: PHRMA - July 30, 2014 Category: Pharmaceuticals Authors: Emily Source Type: news

Update: Progress in Lupus Tx Slow But Sure (CME/CE)
(MedPage Today) -- Progress toward improving the treatment of systemic lupus erythematosus continues to be slow and incremental -- but progress is clearly being made, according to lupus management specialists who spoke with MedPage Today. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - July 24, 2014 Category: Primary Care Source Type: news

Biomedical engineer looks at new applications for novel lupus drug
(University of Houston) Expanding on his work with a new drug that successfully treated lupus in mice, a biomedical engineer at the University of Houston has received a $250,000 grant to expand his research to a new version of the drug in an effort to treat a wider range of autoimmune diseases.The drug that Chandra Mohan and his collaborators at a biopharmaceutical firm are focused on targets B cells, key cells in the immune system that lead to the development of lupus. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 24, 2014 Category: Global & Universal Source Type: news

Living With Lupus: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, Dr. Vai Chowdhary has insights into living with lupus. To listen, click the link below. Living With Lupus (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 24, 2014 Category: Databases & Libraries Source Type: news

An Important Shift in Lupus CareAn Important Shift in Lupus Care
Ronald van Vollenhoven argues that despite somewhat limited data, the time is right for introducing treat-to-target management of SLE. Medscape Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 21, 2014 Category: Consumer Health News Tags: Rheumatology Article Source Type: news

Common drug for Sjögren’s does not help symptoms
Hydroxychloroquine didn’t reduce dryness, pain or fatigue more than placebo Related items from OnMedicaNewer RA drugs no better than old in keeping patients at workThyroid patients need better monitoringDrugs regulators “put profits before patients”Lupus anticoagulant greatly raises stroke risk (Source: OnMedica Latest News)
Source: OnMedica Latest News - July 17, 2014 Category: UK Health Source Type: news

Antiphospholipid Antibodies and Bleeding From Renal BiopsyAntiphospholipid Antibodies and Bleeding From Renal Biopsy
A study identified the clinical and histologic risk factors for bleeding after renal biopsy in patients with lupus nephritis. Medscape Rheumatology (Source: Medscape Rheumatology Headlines)
Source: Medscape Rheumatology Headlines - July 16, 2014 Category: Rheumatology Tags: Rheumatology Viewpoint Source Type: news

Lots of Autoantibodies Equal Lupus?Lots of Autoantibodies Equal Lupus?
No one antibody target or class of autoantibody mark the transition to SLE, but an increasing number of autoantibodies together may be the culprit. Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 11, 2014 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Living with Sjogren’s – When your grin shows, but your illness hides…
An autoimmune disorder is any illness in which the body turns on itself – white blood cells which are designed to protect your body’s intricate systems malfunction and attack. Types of autoimmune disorder are many and varied, but the majority are able to pass under the radar because they chiefly affect the interior working of glands, joints and the nervous system. One example which is prevalent in women aged over 40 is Sjogren’s syndrome. As an invisible illness, this one is quite the heavy-hitter. It may be unfamiliar to you, and you might well be wondering how to even say it! Aptly, Sjogren’s is pronounced ‘Sho...
Source: The Hysterectomy Association - July 3, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Women's Health invisible illness Sjogren’s venus williams Source Type: news

New B-Cell Drug Disappoints in Lupus
(MedPage Today) -- Atacicept, a biologic agent that targets two B-cell factors in patients with moderate-to-severe lupus, failed to meet the primary endpoint in a yearlong phase II/III trial, researchers reported. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - June 25, 2014 Category: Primary Care Source Type: news

Jamesetta Smith - Older Americans
When I think of preventive care, I think of a person who enjoys life, however, when I think of acute care, I am reminded of a person who really does not care, a person who has no concerns of ever being sick. Many have the rationale that we all have to die with something. This is saying to me; do I choose, life, death, pain, suffering, surgery, therapy? There is no question for me; I choose LIFE. My imagination would run away with me if I had not followed the steps which I did when I had symptoms which made me feel as if I was losing my mind and thinking death was my only alternative. The experiences I had 5 years prior to ...
Source: PHRMA - June 18, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news

Jamesetta Smith
PresidentI was born in Chicago, Illinois and raised in Indiana. I graduated from Oxford Business College in Chicago, Illinois. My marriage of 52 years produced 2 sons. Diagnosed with Systemic Lupus Erythematosus February 1986 at Mayo Clinic was a frightening experience for me which lead me to join a Lupus Support Group in Indiana. The Lupus Foundation of America, Inc. requested that I start a lupus support group in Arkansas after we moved to Hot Springs, Arkansas. This support group was started October 1993 and May 1995, we became a chapter. The support group in Indiana gave me my life back and I wanted to do the same for ...
Source: PHRMA - June 18, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news

Dorothy Leone-Glasser
President and CEODorothy Leone-Glasser, RPN, HHC, has lived with systemic lupus for over thirty-five years. As a result, she has overcome two forms of cancer, disabling arthritis, kidney failure, a coma, heart attack, and two strokes. During this time she graduated from a wheelchair to crutches to ultimately walking with her own two feet. Between the ages of 20 and 37, Dorothy received three death sentences imposed by her doctors. Today she is not only alive, but she is living well and paving the way to the future of wellness as President and CEO of the Advocates for Responsible Care (ARxC), a non-profit wellness and advoc...
Source: PHRMA - June 18, 2014 Category: Pharmaceuticals Authors: Sabrina Source Type: news

Genetics Home Reference: systemic lupus erythematosus
http://ghr.nlm.nih.gov/condition/systemic-lupus-erythematosus (Source: NLM General Announcements)
Source: NLM General Announcements - June 17, 2014 Category: Databases & Libraries Source Type: news

In the quest for safer treatment for systemic lupus erythematosus
(University of the Basque Country ) Researchers at the UPV/EHU-University of the Basque Country study what the best treatment is to minimise the side effects of glucocorticoids (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 17, 2014 Category: Global & Universal Source Type: news

Pregnancy Possible in Lupus Patients Taking BelimumabPregnancy Possible in Lupus Patients Taking Belimumab
Successful live births are possible in women with lupus who conceive while taking belimumab, new research shows. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 16, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Stopping Immunotherapy Possible in Some Patients With LupusStopping Immunotherapy Possible in Some Patients With Lupus
Some patients with systemic lupus erythematosus who are in clinical remission with immunosuppressant therapy may be able to stop therapy without triggering a new disease flare. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 15, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Invisible Illness: It’s not easy to combat what you can’t see!
There is a surprising common factor which is shared by a vast range of physical and mental health conditions. Fibromyalgia, anxiety, endometriosis, lupus, endometriosis, pelvic pain and depression may vary in causes and symptoms, but all of them have a deadly weapon in common – invisibility. They are often classed as an invisible illness. These conditions fight their invisible war on two fronts. Firstly, they leave no trace. The majority of these diseases attack the body internally, leaving no external signs which might allow the patient’s suffering to be easily recognised. As well as causing physical pain, invisible i...
Source: The Hysterectomy Association - June 13, 2014 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health Conditions anxiety autoimmune disease depression endometriosis fibromyalgia invisible illness lupus pelvic pain Source Type: news

Pulmonary Manifestations of Systemic Lupus ErythematosusPulmonary Manifestations of Systemic Lupus Erythematosus
Learn more about the clinical presentation, pathogenesis, pathology, management, and prognosis of these SLE-associated lung conditions. Seminars in Respiratory and Critical Care Medicine (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 13, 2014 Category: Consumer Health News Tags: Pulmonary Medicine Journal Article Source Type: news

Anti-dsDNA, surface-expressed TLR4 and endosomal TLR9 cooperate to exacerbate lupus
(Society for Experimental Biology and Medicine) The study by Lee et al. reveals that risk factors, pathogenic anti-dsDNA and combined activation of extracellular and intracellular TLRs, induce SLE syndromes in normal mice. Hence, ongoing studies will determine whether block anti-dsDNA, TLR4 and TLR9 can ameliorate lupus syndrome in lupus mice. Identification of molecular mechanisms contributing to lupus development by co-activation of surface-expressed TLR4 and endo-lysosomal of TLR9 will open new avenues for modulating immune tolerance and suppressing disease progression. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 12, 2014 Category: Global & Universal Source Type: news

New guidance on how and when to stop immunosuppressants in lupus patients
(European League Against Rheumatism) A new study presented today at the European League Against Rheumatism Annual Congress (EULAR 2014) showed that, for the majority of lupus patients who are in remission, it is possible to successfully stop immunosuppressant therapy without triggering a flare of their disease. Within two years, it was possible to stop the immunosuppressant in about 70 percent of clinically stable patients. Half were successful within three years, and this proportion remained stable for up to five years. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 11, 2014 Category: Global & Universal Source Type: news

International Team Creates Heart Disease Risk Tool Tailored to Rheumatoid Arthritis Patients
Method may shed light on how to better gauge heart health in lupus, other inflammatory diseases Rochester, Minn. — Rheumatoid arthritis patients overall are twice as likely as the average person to develop heart problems. Pinpointing which rheumatoid arthritis patients need stepped-up heart disease prevention efforts has been a challenge; research by Mayo Clinic and [...] (Source: Mayo Clinic Rochester News)
Source: Mayo Clinic Rochester News - June 11, 2014 Category: Hospital Management Source Type: news

RheumShorts: Turmeric, Kids' Vasculitis, Autoantibodies (CME/CE)
(MedPage Today) -- This week in rheumatology researchers from around the world reported on the use of curcuminoids for osteoarthritis, autoantibody monitoring for drug-induced lupus, and a rare vasculitis in children. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 30, 2014 Category: Geriatrics Source Type: news

Director's Comments: NIH MedlinePlus Magazine Spring 2014
Listen to the NLM Director's Comments on "NIH MedlinePlus Magazine Spring 2014". The transcript is also available. The new edition of NIH MedlinePlus Magazine Spring 2014 covers rethinking drinking, attention deficit hyperactivity disorder, as well as information about lupus.... (Source: What's New on MedlinePlus)
Source: What's New on MedlinePlus - May 28, 2014 Category: Consumer Health News Source Type: news

No Link Seen Between Vaccines and Lupus
(MedPage Today) -- Recent vaccination was not associated with an increased risk for the development of systemic lupus erythematosus (SLE), a case-control study found. (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - May 28, 2014 Category: Primary Care Source Type: news

IgG Stable With Rituxan in Autoimmune Disease
(MedPage Today) -- Repeated doses of rituximab in patients with vasculitis or lupus had no association with increased rates of low immunoglobulin (Ig)G, an important infection-fighting component of the immune system, a retrospective study found. (Source: MedPage Today Infectious Disease)
Source: MedPage Today Infectious Disease - May 28, 2014 Category: Infectious Diseases Source Type: news

Lupus Therapies Continue to Evolve
May is National Lupus Awareness Month, a time to think about lupus and the challenges it presents to patients. Learn about this chronic, autoimmune disease and the promise of future therapies. (Source: FDA Consumer Updates)
Source: FDA Consumer Updates - May 27, 2014 Category: Consumer Health News Source Type: news

Salad Bars Vanish From Boston Schools
BOSTON (CBS) – Teaching kids about good nutrition is a life lesson, but in Boston Public Schools salad bars have vanished. The move is leaving a sour taste for many parents, as well as the mayor. With First Lady Michelle Obama pushing healthy foods in school, half a dozen Boston schools were among those who bought into lunchroom salad bars in the battle against childhood obesity. A couple years later, none remain – to the chagrin of parents hoping to pry their kids away from junk food. “My little one’s not in school yet, but I’d hope by the time he gets there that they’d have healthy options like salad,...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - May 27, 2014 Category: Consumer Health News Authors: Julie Eich Tags: Education Health Local News Syndicated Local Boston Public Schools Childhood Obesity Healthy Eating mayor marty walsh Salad Bar Source Type: news

Make the diagnosis, Sherlock!
This is a case recently reported in the Medical Journal of Australia.  A 50-year-old woman presented with a read, painful, scaling rash on her hand an forearms, and around her eyes. She reported that sun exposure aggravated the dermal symptoms. She also gave a history of intermittent diarrhea. Examination revealed a scaly hyperpigmented lesion on her upper chest, in the distribution of a broad collar. The patient was a smoker and said she consumed half a bottle of gin daily. The skin manifestations did not respond to antibiotics or steroids. Click on the following questions to reveal the answers. Was is the diagnosis? ex...
Source: The Poison Review - May 22, 2014 Category: Toxicology Authors: Leon Tags: Medical dermatitis niacin deficiency pellagra Source Type: news

AR CAG repeat and autoimmunity in lupus
Clinical and experimental evidence support a role for gonadal steroids in modulating the expression and course of autoimmune diseases such as lupus. It is not known if inherited variation in sensitivity to circulating androgenic hormones could influence the manifestations of such a disease. Olsen and colleagues found that shorter AR CAG repeat lengths in lupus subjects correlated with a higher Systemic Lupus Erythematosus Disease Activity Index score, higher ANA levels, expression of a broader array of IgG autoantibodies, more severe clinical manifestations, and more exuberant humoral autoimmunity. These findings suggest a...
Source: Society for Endocrinology - May 21, 2014 Category: Endocrinology Source Type: news

What Causes Leg Pain?
Discussion “Growing pains” of the legs are a common complaint in children. Heterogeneous studies from 1928-2004 have found prevalence rates of 2.6-49.4% in children ages 4-19. The studies are heterogeneous because of time, location, and especially definition of growing pains. A study of 1445, 4-6 year olds in 2004 using a validated tool showed a prevalence rate of 36.9%. The definition of growing pains used by Peterson in the 2004 study is chronic “…intermittent (nonarticular) pains in both legs that generally occur late in the day or at night…” with a normal physical examination and la...
Source: PediatricEducation.org - May 19, 2014 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Blisibimod Shows Some Promise for Moderate to Severe SLEBlisibimod Shows Some Promise for Moderate to Severe SLE
Blisibimod, an inhibitor of B cell-activating factor (BAFF), improves some endpoints in patients with systemic lupus erythematosus, especially those with more severe disease, according to results from the phase 2 PEARL-SC study. Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 16, 2014 Category: Consumer Health News Tags: Rheumatology News Source Type: news

Treating Lupus: Mayo Clinic Radio Health Minute
In this Mayo Clinic Radio Health Minute, Dr. Vaidehi Chowdhary discusses treatment options for lupus. To listen, click the link below. Treating Lupus (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - May 16, 2014 Category: Databases & Libraries Source Type: news

RheumShorts: New Knees, Lupus Med Switches (CME/CE)
(MedPage Today) -- The news in rheumatology this week included reports on knee replacements in the Dominican Republic, outcomes with scleroderma overlap disease, and reasons for switching maintenance therapy in lupus. (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - May 15, 2014 Category: Geriatrics Source Type: news